Skip to content
10-Q

Quarterly Report

GENERATION BIO CO.

0001558370-24-011360

← back to feed
Filed
Aug 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 2, 2024 66.74M sh
Current Liabilities Q2 2024 · Jun 30, 2024 $30.1M
Current Liabilities Q2 2024 · Dec 31, 2023 $39.91M
Total Liabilities Q2 2024 · Jun 30, 2024 $149.86M
Total Liabilities Q2 2024 · Dec 31, 2023 $171.63M
Current Assets Q2 2024 · Jun 30, 2024 $223.28M
Current Assets Q2 2024 · Dec 31, 2023 $272.62M
Total Assets Q2 2024 · Jun 30, 2024 $265.26M
Total Assets Q2 2024 · Dec 31, 2023 $374.76M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $66.45M
Shares Diluted Q2 2024 · Jun 30, 2023 65.66M sh
Shares Diluted Q2 2024 · Jun 30, 2023 62.96M sh
Capex Q2 2024 · Jun 30, 2023 $2.21M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$2.87M
Stockholders Equity Q2 2024 · Jun 30, 2023 $254.29M
Stockholders Equity Q2 2024 · Mar 31, 2023 $279.14M
Stockholders Equity Q2 2024 · Dec 31, 2022 $282.49M
Eps Diluted Q2 2024 · Jun 30, 2023 −$0.47
Eps Diluted Q2 2024 · Jun 30, 2023 −$1.00
Eps Basic Q2 2024 · Jun 30, 2023 −$0.47
Eps Basic Q2 2024 · Jun 30, 2023 −$1.00
Sga Expense Q2 2024 · Jun 30, 2023 $12.97M
Sga Expense Q2 2024 · Jun 30, 2023 $25.83M
Rd Expense Q2 2024 · Jun 30, 2023 $21.83M
Rd Expense Q2 2024 · Jun 30, 2023 $43.83M
Net Income Q2 2024 · Jun 30, 2023 −$31.07M
Net Income Q2 2024 · Jun 30, 2023 −$63.16M
Operating Income Q2 2024 · Jun 30, 2023 −$33.92M
Operating Income Q2 2024 · Jun 30, 2023 −$68.79M
Revenue Q2 2024 · Jun 30, 2023 $880K
Revenue Q2 2024 · Jun 30, 2023 $880K